Impact of national continuous glucose monitoring reimbursement on utilization and glycemic outcomes in children and adolescents with type 1 diabetes
Acta Diabetologica · 2026
DOI: 10.1007/s00592-026-02753-x ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Diabetologica, 2026. Verfasst von Leyla Kara. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, Health Sciences University, Kayseri City Education and Research Hospital, Kayseri, 147…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Blood Glucose. Die Arbeit nennt 23 Literaturangaben.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Continuous glucose monitoring (CGM) use is associated with improved glycaemic outcomes and reduced hypoglycaemia in type 1 diabetes; however, access remains limited due to cost and reimbursement disparities. METHODS: This retrospective observational study included children and adolescents with type 1 diabetes followed in a single center. Clinical outcomes before and after reimbursement were compared using paired statistical analyses. RESULTS: The implementation of the reimbursement policy in Türkiye was associated with improved access to diabetes technology through reduced financial barriers and with favourable changes in clinical outcomes. CGM usage increased significantly from 26% (n = 11) before reimbursement to 92% (n = 38) after reimbursement. A slight reduction in mean HbA1c levels was observed (from 9.08% to 8.99%). In children under 10 years of age, the proportion achieving target HbA1c levels (< 7%) increased from 16% to 33% (p = 0.042). In addition, a decreasing trend in hypoglycemia frequency and emergency department visits was observed following continuous glucose monitoring use. CONCLUSION: The introduction of a national reimbursement policy was associated with a marked increase in access to CGM in children and adolescents with type 1 diabetes. However, changes in glycaemic outcomes were limited and not statistically significant in the overall cohort. These findings suggest that the primary impact of reimbursement was improved adoption of diabetes technology rather than substantial short-term improvement in glycaemic control. Further large-scale studies are needed to evaluate long-term clinical outcomes and patient-reported benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, Department of Pediatrics, Health Sciences University, Kayseri City Education and Research Hospital, Kayseri, 147026, Turkey. leyladumann@gmail.com.
Zitieren
APA
Kara, L. (2026). Impact of national continuous glucose monitoring reimbursement on utilization and glycemic outcomes in children and adolescents with type 1 diabetes. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02753-x
Vancouver
Kara L. Impact of national continuous glucose monitoring reimbursement on utilization and glycemic outcomes in children and adolescents with type 1 diabetes. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02753-x
BibTeX
@article{Kara2026,
author = {Kara, Leyla},
title = {Impact of national continuous glucose monitoring reimbursement on utilization and glycemic outcomes in children and adolescents with type 1 diabetes},
journal = {Acta Diabetologica},
year = {2026},
doi = {10.1007/s00592-026-02753-x}
}
EUVIMED